Clinical therapeutic value of a new generation of sodium-glucose cotransporter-2 inhibitor ertugliflozin in patients with diabetes and special populations

CHENG Qian; ZOU Shu-peng; SUN Ming-hui

doi:10.3969/j.issn.1003-3734.2023.11.004

Home>Articles>Clinical therapeutic value of a new generation of sodium-glucose cotransporter-2 inhibitor ertugliflozin in patients with diabetes and special populations

DOI: 10.3969/j.issn.1003-3734.2023.11.004

Clinical therapeutic value of a new generation of sodium-glucose cotransporter-2 inhibitor ertugliflozin in patients with diabetes and special populations

CHENG Qian

ZOU Shu-peng

SUN Ming-hui

Machine-generated Keywords：

Publication Date：2023-06-15

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：9( 1099-1107 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2023,32(11)